Oncology The cancer community must seize the opportunity of the Natio... With the government’s National Cancer Plan due for publication this autumn, we have an opportunity to fundamentally improve how we deliver innovation.
News Lilly offers AI discovery models to biotech partners Eli Lilly is offering AI-powered drug discovery models developed at a cost of around $1 billion to biotech companies for free.
News Uni wins big NIHR grant for healthtech 'horizon scanning' A Newcastle University project that gauges whether health technologies can deliver real changes to the NHS has claimed £22m in UK government funding.
News AI picks up interval breast cancers missed by scans An AI could help to detect aggressive interval breast cancers that are diagnosed in between routine screening appointments, say US researchers.
News European Commission approves 2nd IPCEI to sum of €403m The European Commission has approved, under EU State aid rules, the second health-related IPCEI to support innovations in medical devices.
News EVERSANA unveils new AI-powered pharmacovigilance suite EVERSANA has launched a new pharmacovigilance platform to answer the need for advanced analytics and AI in drug safety monitoring and risk management.
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.